News
Avicenna Alliance at VPH2026: a strong community shaping the future of in silico medicine
What a week in Milan! VPH2026 brought together around 650 experts from across the global in silico medicine community, creating an inspiring forum for exchange, collaboration and new ideas.
Avicenna Days (AAD) 2026 New Promo Video
Remember the spirit of Avicenna Days 2026!
Avicenna Alliance Members at VPH Conference 2026
The Avicenna Alliance will be well represented at the VPH Conference 2026 organized by our key …
Ensuring the Quality of In Silico Evidence for Medical Devices - New Peer Reviewed Position Paper
New Avicenna Alliance position paper, co-authored by Marc Horner, Ani Amar, Alejandro F. Frangi, …
Avicenna Alliance publishes the 5th Release of its In Silico Glossary
The Avicenna Alliance ispleased to announce the publication of the 5th Release of the Avicenna …
Computational Modeling and Simulation of Medical Devices - Book Release
The medical device industry is increasingly adopting computational modeling and simulation (CM&S) throughout the product life cycle—from early-stage design and prototyping to regulatory submissions and post-market performance evaluation. A key challenge across all these applications is establishing whether a model is sufficiently credible to support (regulatory) decision-making. The ASME V&V 40 standard, published in 2018, introduced a risk-based framework for assessing model credibility and has gained broad acceptance across the industry.